B Cell Cloning

Services

Talk to a Scientist

Home 5 Service 5 Biologics Discovery 5 B Cell Cloning

ChemPartner expanded our antibody discovery service offering to include B cell cloning in January 2019. The Beacon® platform is capable of screening thousands of plasma B cells from immunized animals, which speeds up a traditionally time-consuming hybridoma process.

Plasma B cells secreting antibodies of interest are selected based on cell- or bead-based binding and/or functional assays that are run serially or by multiplex format. Individual plasma B cells of interest are selectively exported for antibody sequencing. Using this platform, plasma B cells can be characterized in less than eight hours, thus accelerating the antibody discovery process.

B Cell Cloning on the Beacon® Platform

  • Reduce antibody screening time from 8-12 weeks to one day while interrogating more of the immune repertoire
  • Potential to immunize WT or transgenic strains of mice
  • Identify plasma B cells from immunized mice with target specific binding and functional activity
  • Demonstrated functional blocking of receptor/ligand interactions using PD-L1/PD-1 as test case
  • Additional assays such as Ca Flux, cytokine secretion and T cell activation are under development
  • Good rate of recovery of single VH/VL sequences from successfully exported plasma B cells

Beacon® Platform

OptoSelect™ Chip
Light manipulation + microfluidics

Single Cell Isolation in NanoPens™

Thousands in parallel

Single B cells are positioned on a chip housing thousands of sub-nL chambers called NanoPens using controlled patterns of light. Tens of thousands of single B cells can be isolated, cultured, and assayed for target specific binding and function

Typical Output for B Cell Cloning Workflow

Headquarters

1F & 3F, Block A
2829 JinKe Road
Zhangjiang Hi-Tech Park
PuDong New Area
Shanghai China, 201203

w

Contact Us

China: +86 21 5132 0088
US: +1 650 419 9974
Europe: +45 4586 9000

contact@chempartner.com